Life Scientist > Molecular Biology

ComBio: Unravelling the subtleties of telomerase

02 October, 2003 by Melissa Trudinger

The telomeres are intriguing repetitive structures found on the chromosome tips, which are responsible for preventing the gradual erosion of the ends of the chromosomes.


ComBio 2003: Proteomics provides shortcut around antibody shortage

30 September, 2003 by Melissa Trudinger

A predicted shortfall in global production capabilities of monoclonal antibodies for therapeutic purposes has led Queensland researchers to look at ways of boosting production of the antibodies in cell lines.


AGT broadens patent to include cancer, heart disease

29 September, 2003 by Graeme O'Neill

AGT Biosciences has filed to broaden the patent on its SelS gene, already a prime suspect in type 2 diabetes and inflammatory diseases, to cover heart disease, cancer infertility and other disorders.


Benitec appoints RNAi specialist to head US advisory board

18 September, 2003 by Tanya Hollis

Brisbane gene silencing company Benitec (ASX:BLT) has appointed a specialist in DNA-directed RNA interference to chair its scientific advisory board in the United States.


Gribbles enters biotech with genomics coup

17 September, 2003 by Tanya Hollis

Pathology giant Gribbles (ASX:GGL) has announced a new subsidiary dedicated to biotechnology, with its first project being the development of a pre-natal screening test to detect genetic and chromosomal abnormalities.


Protemix aims to take NZ bio to market

12 September, 2003 by Graeme O'Neill

Prof Garth Cooper, CEO of Auckland biopharmaceutical company Protemix Corp, aims to make his company the first New Zealand biotech to take a discovered compound all the way to market.


CogState ponders market options

01 September, 2003 by Melissa Trudinger

Unlisted Melbourne company CogState is contemplating a float on the Australian Stock Exchange, according to CEO Dr Peter Bick.


AGT soars on gene link news

26 August, 2003 by Melissa Trudinger

Shares in AGT Biosciences (ASX:AGT) soared more than 72 per cent to close at AUD$0.62 on Monday after a new study showed one of its licensed target genes was strongly linked to the development of insulin resistance.


Roo genome and other projects off the ground after ARC grants

26 August, 2003 by Graeme O'Neill

Prof Jennifer Marshall Graves' long-awaited Kangaroo Genome Project is up and hopping after last week's federal government announcement of funding for six new Australian Research Council Centres.


AGT Biosciences chases new market

20 August, 2003 by Jeremy Torr

Buoyed by the data from a recent research paper out of Cambridge University, gene discovery biotech AGT Biosciences has announced it has broadened its patent covering PARL (formerly gene AGT203) to cover cancer, aging and some other diseases.


APAF ups the discovery ante

19 August, 2003 by Jeremy Torr

The Australian Proteome Analysis Facility (APAF) has "dramatically increased its throughput capability" with the installation of a new Applied Biosystems 4700 Proteomics Discovery System.


2003 Eureka winners

13 August, 2003 by Susan Williamson

This year's Eureka prizes were awarded last night in their usual black and red finery at a dinner function at Fox studios in Sydney.


Intel chips into a new market

13 August, 2003 by Jeremy Torr

Intel, chip maker to millions of personal computers across the world, is looking hard at the next emerging market -- biotech devices.


New bio-IT firm aims to sort out the rank and file

13 August, 2003 by Melissa Trudinger

It's one thing to design a system that can allow a library of 100,000 compounds to be screened against a protein structure in a day to assess each compound's structural compatibility with the target site. It's another to offer a way to score or rank the compounds according to the best-predicted fit.


New transgene delivery technique takes a traditional route

12 August, 2003 by Graeme O'Neill

An Italian-Australian research partnership has demonstrated a potentially revolutionary technique for producing transgenic animals, using nature's own time-tested vector for delivering genes to eggs: sperm.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd